- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01007305
Bilateral Oophorectomy Versus Ovarian Conservation
August 4, 2011 updated by: University of California, San Francisco
Elective Bilateral Salpingo-oophorectomy Versus Ovarian Conservation: A Pilot Randomized, Controlled Trial
This is a pilot study to assess the feasibility of conducting a randomized, blinded, controlled trial of bilateral salpingo-oophorectomy (BSO, removal of the ovaries and fallopian tubes) versus ovarian conservation among premenopausal women age 40 years and greater who plan to undergo hysterectomy for a benign gynecologic condition.
Subjects will be randomized to BSO or ovarian conservation concomitant with hysterectomy and remain blinded to group assignment.
The primary goal of this pilot is to determine the feasibility of recruiting and retaining study participants in anticipation of conducting a larger, multi-centered trial.
However, the investigators will also obtain baseline data and follow-up measures at 6 weeks and 6 months after surgery.
Outcomes will be assessed in several domains that the investigators hypothesize may be effected by oophorectomy: cardiovascular health, skeletal health, sexual functioning, and health-related quality-of-life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States
- University of Alabama at Birmingham
-
-
California
-
San Francisco, California, United States, 94115
- University of California, Sans Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Plans to undergo hysterectomy for any non-cancerous gynecologic condition, including symptomatic fibroids, abnormal bleeding, pelvic pain, or pelvic organ prolapse. Hysterectomy may be done abdominally, vaginally or laparoscopically
- Premenopausal defined as having at least one menses in the 3 months prior to surgery
- Age > or = 40 years
- Speaks English or Spanish
Exclusion Criteria:
- Personal or family history of breast and/or ovarian cancer (at least one first degree relative with a diagnosis of breast or ovarian cancer) or a known BRCA mutation
- Known or suspected adnexal mass by physical exam or radiologic imaging study
- Gynecologist recommends BSO for treatment of pelvic pain and/or endometriosis
- Known history of coronary heart disease defined as any of the following: prior myocardial infarction, history of angioplasty, history of angina, admission to the hospital for evaluation of chest pain, or use of nitroglycerin to treat angina
- History of stroke
- History of osteoporosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bilateral salpingo-oophorectomy
Removal of both ovaries and fallopian tubes at the time of hysterectomy for benign conditions.
|
Removal of both ovaries and fallopian tubes at the time of hysterectomy
|
Active Comparator: Ovarian conservation
No ovaries or fallopian tubes removed at the time of hysterectomy for benign conditions.
|
Both ovaries and fallopian tubes not removed at the time of hysterectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Recruitment rate
Time Frame: start of study
|
start of study
|
Flow-mediated diameter of the brachial artery
Time Frame: Baseline and 6 months follow-up
|
Baseline and 6 months follow-up
|
Serum bone turnover markers
Time Frame: Baseline and 6 months follow-up
|
Baseline and 6 months follow-up
|
Sexual functioning and quality-of-life questionnaires
Time Frame: Baseline and 6 month follow-up
|
Baseline and 6 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
November 3, 2009
First Submitted That Met QC Criteria
November 3, 2009
First Posted (Estimate)
November 4, 2009
Study Record Updates
Last Update Posted (Estimate)
August 5, 2011
Last Update Submitted That Met QC Criteria
August 4, 2011
Last Verified
November 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- BSO 01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Universita di VeronaRecruiting
-
Medical University of South CarolinaRecruiting
-
Memic Innovative SurgeryRecruiting
-
Indiana UniversityCompleted
-
Queensland Centre for Gynaecological CancerQueensland University of TechnologyCompleted
-
Copenhagen University Hospital at HerlevTerminated
Clinical Trials on Bilateral salpingo-oophorectomy
-
Ismet HortuCompletedOxidative Stress | Ischemia Reperfusion Injury | OophorectomyTurkey
-
University Medical Center NijmegenActive, not recruitingOvarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene MutationNetherlands
-
National Taiwan University HospitalNational Science Council, TaiwanUnknownMenopause, Premature | Hysterectomy | Attitude | Perception | Ovariectomy | Estrogen Replacement TherapyTaiwan
-
Lei LiRecruitingColorectal Neoplasms, Hereditary Nonpolyposis | Hysterectomy | Hereditary Breast and Ovarian Cancer Syndrome | OvariectomyChina
-
University Medical Center NijmegenRecruitingOvarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene MutationNetherlands
-
Moscow City Oncology Hospital No. 62Active, not recruitingEndometrial Neoplasms | Endometrial Cancer | Sentinel Lymph Node | Endometrial Endometrioid Adenocarcinoma | Endometrial Adenocarcinoma | Hysterectomy | Endometrial Cancer Stage I | Laparoscopic Hysterectomy | Endometrial Cancer Stage IIRussian Federation
-
NRG OncologyNational Cancer Institute (NCI)RecruitingOvarian CarcinomaUnited States, Korea, Republic of
-
M.D. Anderson Cancer CenterRecruitingFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingOvarian Cancer | Fallopian Tube CancerUnited States
-
M.D. Anderson Cancer CenterActive, not recruiting